Capricor Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -20,359 | -22,047 | -18,915 | |
EBITDA | -29,157 | -24,075 | -27,232 | -24,577 |
EBIT | -24,570 | -27,719 | -24,982 | |
Net Income | -30,170 | -24,570 | -25,910 | -24,391 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -28,691 | -23,698 | -21,571 | -7,573 |
Cash | 287,847 | 19,510 | 23,241 | 28,794 |
Basic Shares | 48,850 | 45,716 | 45,709 | 45,637 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $22,270 | $25,178 | $2,551 |
Gross Profit | -27,698 | -11,269 | -19,265 | |
EBITDA | -108,142 | -41,139 | -23,008 | -29,164 |
EBIT | -42,564 | -24,077 | -29,697 | |
Net Income | -105,043 | -40,467 | -22,287 | -29,019 |
Net Change In Cash | 0 | 22,270 | 25,178 | 2,551 |
Cost of Revenue | -25,282 | |||
Free Cash Flow | -72,715,722 | -41,534 | -27,644 | 1,556 |
Cash | 287,847 | 11,286 | 14,694 | 9,603 |
Basic Shares | 46,478 | 35,219 | 26,778 | 24,552 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.62 |
2025-09-30 | -$0.54 |
2025-06-30 | -$0.57 |
